VinFast, Arm and Other Index Orphans Miss Out on Billions From Passive Investors
Two current market favorites are caught in a weird limbo thanks to their decisions on where to list their shares
Source: wsj.com
📰 Biontech Se News
Page 7 - Biontech Se News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biontech Se. Real-time updates on events, politics, business and more.
The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage.
Hawaiian Electric suspends dividend as troubles build, fast-fashion rivals Shein and Forever 21 team up, and other news to start your day.
Jackson Hole Nasdaq Composite Article Normal Computers Consumer Electronics Wooden Furniture Market Research Public Relations
Source: marketwatch.com
Covid Boosters Will Come Later Than Last Year, Despite Rising Hospitalizations
The variant that the updated vaccines were designed to target has already all-but-disappeared from the U.S., and new ones have emerged.
Josh Nathan Kazis Christopher Ridley Mandy Cohen Centers For Disease Human Services Department Drug Administration
Source: marketwatch.com
Covid Hospitalizations Jump. So Could Vaccine Demand.
Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.
Source: marketwatch.com
Covid-19 Hospitalizations Jump. So Could Vaccine Demand.
Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.
Source: marketwatch.com
Covid vaccine stocks jump as new variants emerge
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
Us Health Us Centers For Disease World Health Organization Wall Street Disease Control Biotech And Pharmaceuticals
Source: cnbc.com
Moderna and BioNTech Both Have Strong Drug pipelines and Plenty of Cash.
Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.
Source: marketwatch.com
BioNTech SE Posts Loss In Q2; Reiterates COVID-19 Vaccine Revenue Guidance
BioNTech SE (BNTX) posted a second-quarter net loss of 190.4 million euros, compared to profit of 1.67 billion euros, last year. Loss per share was 0.79 euros, compared to profit of 6.
Source: rttnews.com
BioNTech Stock Falls as Covid-19 Vaccine Maker Misses Revenue Estimates
Sales drop by more than expected in the second quarter, but BioNTech says its new 'variant-adapted Covid-19 vaccine' is still on track.
Source: marketwatch.com
Stocks making the biggest moves premarket: SOVO, BNTX, TSN
Shares of Rao's parent Sovos Brands' popped 25% in premarket trading on news that Campbell Soup will acquire the pasta sauce maker for $2.33 billion.
Source: cnbc.com